CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-15 | Blanchfield Paul Chief Operating Officer | Grant or award | +3,211 | 77,357 | ||
| 2022-07-15 | Blanchfield Paul Chief Operating Officer | Grant or award · Stock Option (right to buy) | +5,425 | 5,425 | ||
| 2022-07-15 | Sabens Andrea Chief Accounting Officer | Sale | −386 | $69.12 | $27K | 64,255 |
| 2022-06-15 | Sabens Andrea Chief Accounting Officer | Sale | −386 | $62.87 | $24K | 64,441 |
| 2022-05-18 | Niedzwiecki Daniel | Sale | −1,380 | $64.54 | $89K | 71,143 |
| 2022-05-16 | Marshall Robert J. Jr. CFO and Treasurer | Sale | −10,000 | $63.27 | $633K | 135,893 |
| 2022-05-13 | Blanchfield Paul Chief Commercial Officer | Sale | −2,285 | $60.95 | $139K | 74,146 |
| 2022-05-13 | Blanchfield Paul Chief Commercial Officer | Gift | −785 | 785 | ||
| 2022-05-11 | McHugh Julie Director | Sale | −2,980 | $57.84 | $172K | 30,770 |
| 2022-05-10 | Ber Gerard Director | Sale | −1,277 | $58.19 | $74K | 32,703 |
| 2022-05-09 | Heino Mary Anne President & CEO | Sale | −625 | $58.59 | $37K | 706,766 |
| 2022-05-09 | Heino Mary Anne President & CEO | Sale | −2,173 | $59.63 | $130K | 704,593 |
| 2022-05-09 | Heino Mary Anne President & CEO | Sale | −2,978 | $60.61 | $180K | 701,615 |
| 2022-05-09 | Heino Mary Anne President & CEO | Sale | −3,400 | $61.55 | $209K | 698,215 |
| 2022-05-09 | Heino Mary Anne President & CEO | Sale | −2,100 | $62.60 | $131K | 696,115 |
| 2022-05-09 | Heino Mary Anne President & CEO | Sale | −1,000 | $63.71 | $64K | 695,115 |
| 2022-05-06 | Ber Gerard Director | Grant or award · Stock Option (right to buy) | +4,068 | 4,068 | ||
| 2022-05-06 | Maeusli Heinz Christoph Director | Grant or award · Stock Option (right to buy) | +4,068 | 4,068 | ||
| 2022-05-06 | Baylor-Henry Minnie Director | Grant or award · Stock Option (right to buy) | +4,068 | 4,068 | ||
| 2022-05-06 | LENO SAM R Director | Grant or award · Stock Option (right to buy) | +4,068 | 4,068 |
Page 20 of 27 · 534 trades